Moclobemide
Moclobemide.JPG

CLINICAL USE

Reversible MAOI:Depression Social phobia

DOSE IN NORMAL RENAL FUNCTION

Depression: 150–600 mg daily in divided dosesSocial phobia: 300 mg twice daily

PHARMACOKINETICS

  • Molecular weight                           :268.7
  • %Protein binding                           :50
  • %Excreted unchanged in urine     : <1
  • Volume of distribution (L/kg)       :1
  • half-life – normal/ESRD (hrs)      :2–4/unchanged

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Likely dialysability. Dose as in normal renal function
  • HD                     :Likely dialysability. Dose as in normal renal function
  • HDF/high flux   :Likely dialysability. Dose as in normal renal function
  • CAV/VVHD      :Likely dialysability. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Analgesics: possible CNS excitation or depression with dextromethorphan or pethidine – avoid concomitant use; possible CNS excitation or depression with opioid analgesics
  • Antidepressants: avoid concomitant use; possible increased serotonergic effects with duloxetine
  • Antimalarials: avoid concomitant use with artemether/lumefantrineBupropion: avoid concomitant use
  • Dopaminergics: use with caution with entacapone; increased side effects with levodopa; avoid concomitant use with selegiline5HT 1 agonists: increased CNS toxicity with rizatriptan and sumatriptan – avoid concomitant use; increased CNS toxicity with zolmitriptan – reduce zolmitriptan dose
  • Sibutramine: increased CNS toxicity – avoid concomitant use
  • Sympathomimetics: risk of hypertensive crisis

    ADMINISTRATION

    Reconstition

    Route

    Oral

    Rate of Administration

    Comments

    Take after food

    OTHER INFORMATION

    Hyponatraemia has been reported (especially in elderly patients) due to inappropriate secretion of antidiuretic hormone.



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs